AIM - AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference | Benzinga
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company"), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Conference on Monday, June 17, 2024 at 1:00 PM ET.
As part of the event, Mr. Equels will provide an "elevator pitch" and outline the Company's upcoming ...